Interestingly, our date showed that increased MSH6 and PMS2 mRNA levels were correlated with a favorable OS in serous ovarian cancer, but not in endometrioid ovarian cancer. This evidence concerns the gene PMS2 and ovarian endometrioid adenocarcinoma.